To evaluate if long-term pessary use is associated with a change in pelvic organ prolapse (POP) severity and genital hiatus (GH) size. MATERIALS AND METHODS: This is a retrospective study of women using pessaries for treatment of symptomatic POP and/or incontinence from January 2014 to April 2017 at a single urogynecology practice. Baseline and most recent pelvic organ prolapse quantification (POPQ) measurements and stages were recorded. The primary outcome was change in POPQ point GH. Secondary outcomes included change in POPQ stage, type of pessary (e.g., space-filling or support), size of pessary, number of pessary changes over time (e.g., size and/or type of pessary), and duration of use. Demographic characteristics were analyzed using descriptive statistics. Student t test and Mann-Whitney tests were used to compare categorical data as appropriate. Pearson's and Spearman's correlation coefficients were used where appropriate for evaluation of change over time. RESULTS: A total of 132 patients were included in the analysis. The cohort was predominantly non-Hispanic white (75%) women using pessaries for symptomatic POP greater than stage 2 (70.5%). All patients were post-menopausal. Median duration of pessary use was 39.5 months (IQR 17-64.5 months). POPQ point GH (r ¼ -0.215, p ¼ 0.014) and POPQ stage (r ¼ -0.276, p ¼ 0.001) decreased significantly as duration of pessary use increased. Compared to patients with baseline POPQ stage <3, those with baseline POPQ stages 3 had a significant decrease in GH as duration of pessary use increased (-0.5 cm vs. 0 cm, p <0.001). This relationship was not seen when comparing baseline GH <3 cm to those with baseline GH 3 cm. Patients underwent a significant number of changes in pessary type over time (p < 0.001); however, there was no significant change in the size of pessary over time (p ¼ 0.191). CONCLUSION: Pessary use by women with pelvic organ prolapse causes a change in vaginal anatomy over time as seen by decreasing POPQ stage and point GH. Prospective studies are needed to further characterize and confirm these findings. 
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26 Effect of an attending mentoring program on physician confidence in performing laparoscopic and vaginal hysterectomies J. Heft, J. Panza, R. Alvarez, R. R. Dmochowski, C. W. Zimmerman
Vanderbilt University, Nashville, TN OBJECTIVES: The primary aim of this study was to evaluate the change in confidence level of OB/GYN Specialist Attendings (SAs) with the enactment of an Attending Mentoring Program (AMP) for laparoscopic hysterectomies (LHs) and vaginal hysterectomies (VHs). MATERIALS AND METHODS: SAs at our institution who had performed at least one hysterectomy in the previous 12 months were invited to participate in the AMP. Baseline and 6-month post-AMP confidence levels in performing LH and VH were obtained using a Visual Analog Scale (VAS). Once SAs found an appropriate patient, the anticipated route of hysterectomy and accompanying mentor were identified. LH mentors were members of the Minimally Invasive Gynecologic Surgeon Division. VH mentors were members of the Female Pelvic Medicine & Reconstructive Surgery Division. The cases were then performed with the mentor as the first assistant during resident didactics, when residents typically do not perform surgeries, so as not to affect resident education. The change in VAS scores over six months was calculated. Secondary outcomes of operative time, estimated blood loss (EBL), length of admission (LOA), and postoperative complication rates were recorded for comparison to SA-only hysterectomies. RESULTS: Thirteen SAs met inclusion criteria for this study and agreed to participate. CONCLUSION: Confidence levels of OB/GYN Specialist Attendings in performing laparoscopic hysterectomies increased over the course of six months when the AMP was implemented. Though an increase in VAS confidence scores for vaginal hysterectomy was seen, this was not statistically significant which may be due to the relatively low number of these surgeries performed. There was no difference in operative time, estimated blood loss, length of admission, or postoperative complications.
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27 Pilot study: investigating oral agents for urine staining to facilitate intraoperative observation of ureteral jets
Russell Stanley
Obstetrics and Gynecology, Texas Tech University Health Sciences Center, Lubbock, TX OBJECTIVES: This study evaluates oral agents used to visualize ureteral jets at the time of intraoperative cystoscopy. Agents examined by the study are oral pyridium and vitamin B riboflavin. The study looks to determine if administration of a standard oral dose of vitamin B riboflavin is a comparable oral agent to pyridium for evaluating patency of ureteral jets at the time of intraoperative cystoscopy. MATERIALS AND METHODS: A three-arm, double-blinded, randomized controlled pilot study was performed. Group 1 was administered pyridium, Group 2 was administered vitamin B riboflavin, and group 3 was administered thiamine as a placebo. The surgeons and patients Non-Oral Posters ajog.org
